Note 13 - Subsequent Events
|12 Months Ended|
Jun. 30, 2018
|Notes to Financial Statements|
|Subsequent Events [Text Block]||
July 2, 2018,the Company acquired QT Holdings Corporation (Quad) for approximately
$51million in potential milestone payments. On
August 1, 2018,the Company acquired Exosome Diagnostics, Inc. (Exosome) for approximately
$325million in potential milestone payments. The purchase accounting for these acquisitions are in progress.
In connection with the acquisition of Exosome Diagnostics, Inc. on
August 1, 2018,the Company entered into a new credit facility that provides for a revolving credit facility of
$600million, which can be increased by an additional
$200million subject to certain conditions, and a term loan of
$250million. The credit facility is governed by a Credit Agreement dated
August 1, 2018and matures on
August 1, 2023.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef